DNAprint Genomics (DNAG)

[mingwan0]

66fan, we have looked at Julie before:

http://www.medicine.ufl.edu/cardio/research/biomarker/JulieBio.shtml

http://www.orchid.com/news/view_pr.asp?ID=231

http://pharmacy.ouhsc.edu/academics/lecture/ashby/jjohnson.asp

http://www.hum-molgen.de/meetings/meetings/1828.html

Johnson JA. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet. 2003 Nov;19(11):660-6.

Johnson JA, Evans WE. Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity. Trends Mol Med. 2002 Jun;8(6):300-5. Review.

Evans WE, Johnson JA. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet. 2001;2:9-39. Review.

She has also been in the press recently:

http://www.ascpt.org/press/2004/2004Johnson.htm

Johnson's work focuses on cardiovascular disease-gene associations and the influence of race and ethnicity on drug responses. She investigates hypertension, heart failure, ischemic heart disease and obesity focusing on the proteins that drugs target and the impact of genetics on drug responses.

Wouldn't surprise me if there was a connection here...